Hypersensitivity Reaction
- HIV/AIDS Update -- New Intelence Labeling: Severe Skin and Hypersensitivity Reactions (August 2009)
Important drug warning.
To read PDF, click here.
From Tibotec Therapeutics
- Black or White, Ziagen Hypersensitivity Test Works Equally Well, Study Finds (April 1, 2008)
From aidsmap.com
- Can HLA-B*5701 Testing Help Avoid Abacavir Hypersensitivity Reaction? (July 25, 2007)
Avoiding abacavir hypersensitivity reaction may be as easy as screening for the HLA-B*5701 allele in any HIV-infected, abacavir-naive patient for whom abacavir therapy is being considered. Graeme Moyle, M.D., reports.
In 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO
- Abacavir Hypersensitivity Test Could Be Combined With Drug Resistance Test: Study (June 4, 2007)
From aidsmap.com
- Momentum for HLA-B*5701 Testing to Prevent Abacavir Hypersensitivity Grows (November 16, 2006)
In 8th International Congress on Drug Therapy in HIV Infection
- Abacavir Hypersensitivity Becoming Easier to Predict Using Pharmacogenetic Markers (August 16, 2006)
In XVI International AIDS Conference
- Abacavir Hypersensitivity: Could the Trigger Be in Your Genes? (May 2, 2006)
From aidsmap.com
- Low Incidence of Abacavir Hypersensitivity Reaction in Treatment-Naive and -Experienced Patients (July 26, 2005)
[Archived Article]
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
- Severity and Rate of Abacavir Hypersensitivity Reactions Higher Than Previously Believed (February 23, 2005)
[Archived Article]
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Abacavir Hypersensitivity Reaction Predicted by Genetic Test (March 26, 2004)
[Archived Article]
Research in Australia suggests the experimental test could drastically reduce hypersensitivity reactions, but is prone to false positives.
In AIDS Treatment News, from AIDS Treatment News
- Clinical Risk Factors for Hypersensitivity Reactions to Abacavir: Side Effects of Antiretroviral Therapy (September 17, 2003)
[Archived Article]
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Secondary Syphilis and Abacavir Hypersensitivity Reaction (October 26, 2002)
[Archived Article]
In 40th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO
- HLA-B57 and TNF-Alpha Variants Associated With Hypersensitivity Reactions to Abacavir Among HIV-1-Positive Subjects (February 27, 2002)
[Archived Article]
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- The Presence of HLA-B*5701, -DRB1*0701, and -DQ3 Is Highly Predictive of Hypersensitivity to the HIV Reverse Transcriptase Inhibitor Abacavir (February 27, 2002)
[Archived Article]
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Comparison of Symptoms of Influenza A Infection With Abacavir-Associated Hypersensitivity Reaction (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Epidemiological Risk Factors and Immunological Mechanisms of Hypersensitivity Reactions to Abacavir (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Approach to Hypersensitivity Syndromes Associated With Antiretroviral Agents (December 2000)
[Archived Article]
In The PRN Notebook
|
Advertisement
|
Email
Glossary
